WASHINGTON, Nov 20 (Reuters) - Salesforce said Thursday it is investigating “unusual activity” involving Gainsight-published applications that may have exposed customer data. In a brief statement, ...
In a world where data sits at the heart of organizational activities, CIOs and their business peers more than ever need ways to bring information together. With the rise of generative and agentic AI, ...
The amount of capital pouring into AI data center projects is staggering. Last week, Microsoft, Alphabet, Meta, and Amazon reported their 2025 capital expenditures would total roughly $370 billion, ...
Have you ever spent hours wrestling with messy spreadsheets, only to end up questioning your sanity over rogue spaces or mismatched text entries? If so, you’re not alone. Data cleaning is one of the ...
Perhaps in the earlier days of AI/ML, you were a little curious about what the limiting factors would be in these new technologies. One potential one was cost, but we’ve seen the value of compute ...
XNO is an AI-powered stock trading platform combining DataQuant and AI Auto Trading to deliver advanced trading solutions. We are seeking a Quant Data Engineer to build and optimize our data ...
1. Erasmus MC Center of Expertise for Inherited Cardiovascular Diseases, Rotterdam, the Netherlands 2. Centre for Heart Muscle Disease, University College London (UCL), UK 3. Inherited Cardiovascular ...
Personal Data Servers are the persistent data stores of the Bluesky network. It houses a user's data, stores credentials, and if a user is kicked off the Bluesky network the Personal Data Server admin ...
Teledyne Controls, a business unit of Teledyne Technologies Incorporated (NYSE:TDY), and a leading provider of avionics and aircraft data management solutions, is pleased to announce that the Federal ...
Workday Rising 2025 opens with announcements of new AI agents for HCM and finance, but the big news is the new Workday Build developer platform and Data Cloud, along with consumption-based pricing.
Genotypic Status Identified as a Significant Predictor of Risk and Left Ventricular Mass Index May Serve as a Surrogate Marker for Poor Long-Term Outcomes SOUTH SAN FRANCISCO, Calif., Aug. 31, 2025 ...
During a medical event on Saturday, Cytokinetics (NASDAQ:CYTK) announced primary results from its Phase 3 MAPLE-HCM trial for lead asset aficamten in symptomatic obstructive hypertrophic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results